Found 4370 articles for: ""
Solitary Mastocytoma Successfully Treated with a Moderate Potency Topical Steriod
May 2004 | Volume 3 | Issue 3 | Case Reports | 309 | Copyright © May 2004
We report a case of solitary mastocytoma in a child which was successfully treated with a topical steroid of moderate potency. The patient was an 18-month-old girl who presented with localized oval s...
Read MoreSerum Sickness due to Infliximab in a Patient with Psoriasis
May 2004 | Volume 3 | Issue 3 | Case Reports | 305 | Copyright © May 2004
Infliximab is a chimeric, murine-human, monoclonal antibody against tumor necrosis alpha which has shown great efficacy in the treatment of psoriasis. Serum sickness, which is an immune complex media...
Read MoreFollicular Mycosis Fungoides: Successful Treatment with Oral Bexarotene
May 2004 | Volume 3 | Issue 3 | Case Reports | 301 | Copyright © May 2004
Follicular mycosis fungoides, a subtype of cutaneous T-cell lymphoma, is often difficult to treat. We present a case of a female with follicular mycosis fungoides who showed an excellent response to ...
Read MoreThe IFRA: Working Towards the Continually-Improved Safety of Fragrance Ingedients and the Importance of a Partnership with the Dermatological Community
May 2004 | Volume 3 | Issue 3 | Original Article | 297 | Copyright © May 2004
The relationship between the fragrance industry and the dermatological community in the past has not always been perceived as one of partnership. IFRA, the International Fragrance Association, has st...
Read MoreAntiandrogen Oligonucleotides: Active Principles in Hair-and Skin-Derived Culute Cells
May 2004 | Volume 3 | Issue 3 | Original Article | 287 | Copyright © May 2004
Most drugs used for treatment of androgen-related dermatological disorders are not completely satisfactory in terms of clinical efficacy and potential secondary effects. There is, therefore, a need f...
Read MoreOff-label Uses and Side Effects of Infliximab
May 2004 | Volume 3 | Issue 3 | Original Article | 273 | Copyright © May 2004
Infliximab was first approved by the FDA in 1998 as a treatment of moderately-to-severely active Crohn’s disease in patients who have an inadequate response to conventional therapies, and fistulizi...
Read MoreEtanercept for the Treatment of Psoriasis: Combination Therapy with other Modalities
May 2004 | Volume 3 | Issue 3 | Original Article | 270 | Copyright © May 2004
Etanercept is a self-administered medication that has FDA approval for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Etanercep...
Read MoreLong-Term Fat Preservation
May 2004 | Volume 3 | Issue 3 | Original Article | 266 | Copyright © May 2004
The injection of autologous free fat obtained by suction-assisted lipectomy for the correction of soft tissue defects is a common procedure in plastic surgery. However, unpredictable partial absorpti...
Read MoreIntralesional Immunotherapy for Warts Using a Combination of Skin Test Antigens
May 2004 | Volume 3 | Issue 3 | Original Article | 263 | Copyright © May 2004
Warts are a common dermatologic problem. There are many treatments available. Intralesional injection of a skin test antigen has been shown to be efficacious at eradicating all warts when only a part...
Read MoreRosacea: Where Are We Now?
May 2004 | Volume 3 | Issue 3 | Original Article | 251 | Copyright © May 2004
Advances continue to be made in the classification and treatment of rosacea, a chronic dermatologic syndrome. A new empiric classification system identifies 4 rosacea subtypes (erythematotelangiectat...
Read MoreNew Insights into Imiquimod's Mechanisims of Action
May 2004 | Volume 3 | Issue 3 | Original Article | 247 | Copyright © May 2004
Imiquimod, an immune response modifier with potent antiviral and antitumor properties, has been reported to be effective in the treatment of various cutaneous neoplasms. Besides stimulating the produ...
Read MoreClinical Trial Review
March 2004 | Volume 3 | Issue 2 | Features | 222 | Copyright © March 2004
Washington Whispers
March 2004 | Volume 3 | Issue 2 | Features | 218 | Copyright © March 2004
Pipeline Previews
March 2004 | Volume 3 | Issue 2 | Features | 215 | Copyright © March 2004
The Revolutionary Field of Chemoprevention
March 2004 | Volume 3 | Issue 2 | Case Reports | 209 | Copyright © March 2004
Treatment of Hailey-Hailey Disease with Tacrolimus Ointment and Clobetasol Propionate Foam
March 2004 | Volume 3 | Issue 2 | Case Reports | 200 | Copyright © March 2004
Hailey-Hailey disease, or familial benign chronic pemphigus, is a chronic disease without a known cure. Current therapeutic strategies attempt to suppress Hailey-Hailey outbreaks and allow the patien...
Read MoreDelayed Type Hypersensitivity to Benzoyl Peroxide
March 2004 | Volume 3 | Issue 2 | Case Reports | 197 | Copyright © March 2004
Benzoyl peroxide (BP) has been a standard and effective topical treatment for acne vulgaris for the past 35 years. Previous studies and case reports have documented benzoyl peroxide to be a strong ir...
Read MoreKeratoacanthoma Arising from an Excisional Surgery Scar
March 2004 | Volume 3 | Issue 2 | Case Reports | 193 | Copyright © March 2004
A causal relationship between keratoacanthomas and a variety of preceding traumatic events has been postulated in the literature. We report a patient who developed a keratoacanthoma at the site of a ...
Read MoreCutaneous Ulcerative Lichen Planus Exhibiting Pathergy, Response to Acitretin
March 2004 | Volume 3 | Issue 2 | Original Article | 191 | Copyright © March 2004
While ulcerative lichen planus is a common diagnosis when involving the mucosa, it is uncommonly found on the cutaneous surface. Cutaneous ulcerative lichen planus is usually found on the palmar or p...
Read MoreThe Successful Use of ALA-PDT in the Treatment of Recalcitrant Mollusum Contagiosum
March 2004 | Volume 3 | Issue 2 | Case Reports | 187 | Copyright © March 2004
Photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) has been shown to be safe and effective for a variety of skin concerns. The case report described is the first successfully documen...
Read More